Karolinska Development: Where we stand after resolved on short-term finances (Redeye)
In November, after months of negotiations, 94.2 percent of the convertible holders committed to converting or repurchase. Since then, the company has repaid the remaining part of the convertible loan and secured short-term finances via a loan of SEK 70 million from Sino Biopharma (largest shareholder in KD). This is where we stand regarding our coverage.
Redeye AB - Redeye.se